BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 20922526)

  • 1. The role of zinc protoporphyrin measurement in the differentiation between primary myelofibrosis and essential thrombocythaemia.
    Metzgeroth G; Kanders EM; Erben P; Hofmann WK; Hastka J
    Ann Hematol; 2011 Apr; 90(4):389-94. PubMed ID: 20922526
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Zinc protoporphyrin, a useful parameter to address hyperferritinemia.
    Metzgeroth G; Schultheis B; Dorn-Beineke A; Hehlmann R; Hastka J
    Ann Hematol; 2007 May; 86(5):363-8. PubMed ID: 17333188
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is zinc protoporphyrin an indicator of iron-deficient erythropoiesis in maintenance haemodialysis patients?
    Braun J; Hammerschmidt M; Schreiber M; Heidler R; Hörl WH
    Nephrol Dial Transplant; 1996 Mar; 11(3):492-7. PubMed ID: 8671820
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The measurement of erythrocyte zinc protoporphyrin/heme ratio in various anemias in childhood].
    Kitajima H; Kaneko T; Akatsuka J
    Rinsho Ketsueki; 1992 Sep; 33(9):1199-203. PubMed ID: 1433941
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Soluble transferrin receptor and zinc protoporphyrin--competitors or efficient partners?
    Metzgeroth G; Adelberger V; Dorn-Beineke A; Kuhn C; Schatz M; Maywald O; Bertsch T; Wisser H; Hehlmann R; Hastka J
    Eur J Haematol; 2005 Oct; 75(4):309-17. PubMed ID: 16146537
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Central role of zinc protoporphyrin in staging iron deficiency.
    Hastka J; Lasserre JJ; Schwarzbeck A; Hehlmann R
    Clin Chem; 1994 May; 40(5):768-73. PubMed ID: 8174250
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transferrin receptor assay and zinc protoporphyrin as markers of iron-deficient erythropoiesis in end-stage renal disease patients.
    Baldus M; Walter H; Thies K; Anders C; Stein M; Hellstern P; Brass H
    Clin Nephrol; 1998 Mar; 49(3):186-92. PubMed ID: 9543601
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thrombospondin-1 (TSP-1) in primary myelofibrosis (PMF) - a megakaryocyte-derived biomarker which largely discriminates PMF from essential thrombocythemia.
    Muth M; Engelhardt BM; Kröger N; Hussein K; Schlué J; Büsche G; Kreipe HH; Bock O
    Ann Hematol; 2011 Jan; 90(1):33-40. PubMed ID: 20625903
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Washing erythrocytes to remove interferents in measurements of zinc protoporphyrin by front-face hematofluorometry.
    Hastka J; Lasserre JJ; Schwarzbeck A; Strauch M; Hehlmann R
    Clin Chem; 1992 Nov; 38(11):2184-9. PubMed ID: 1424108
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Survival and disease progression in essential thrombocythemia are significantly influenced by accurate morphologic diagnosis: an international study.
    Barbui T; Thiele J; Passamonti F; Rumi E; Boveri E; Ruggeri M; Rodeghiero F; d'Amore ES; Randi ML; Bertozzi I; Marino F; Vannucchi AM; Antonioli E; Carrai V; Gisslinger H; Buxhofer-Ausch V; Müllauer L; Carobbio A; Gianatti A; Gangat N; Hanson CA; Tefferi A
    J Clin Oncol; 2011 Aug; 29(23):3179-84. PubMed ID: 21747083
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Different immunophenotypical apoptotic profiles characterise megakaryocytes of essential thrombocythaemia and primary myelofibrosis.
    Florena AM; Tripodo C; Di Bernardo A; Iannitto E; Guarnotta C; Porcasi R; Ingrao S; Abbadessa V; Franco V
    J Clin Pathol; 2009 Apr; 62(4):331-8. PubMed ID: 19329711
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Red cell zinc protoporphyrin and its ratio to serum ferritin (ZPP/logSF index) in the detection of iron deficiency in patients with end-stage renal failure on hemodialysis].
    Matuszkiewicz-Rowińska J; Ostrowski G; Niemczyk S; Przedlacki J; Wardyn K; Puka J; Włodarczyk D; Switalski M; Zakrzewska T; Ostrowski K
    Pol Arch Med Wewn; 2003 Jul; 110(1):703-10. PubMed ID: 14682204
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative analysis of zinc protoporphyrin and blood lead levels in lead-exposed Andean children.
    Counter SA; Buchanan LH; Ortega F; Rifai N; Shannon MW
    Clin Biochem; 2007 Jul; 40(11):787-92. PubMed ID: 17462618
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic utility of zinc protoporphyrin to detect iron deficiency in Kenyan pregnant women.
    Mwangi MN; Maskey S; Andang o PE; Shinali NK; Roth JM; Trijsburg L; Mwangi AM; Zuilhof H; van Lagen B; Savelkoul HF; Demir AY; Verhoef H
    BMC Med; 2014 Nov; 12():229. PubMed ID: 25428714
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Zinc protoporphyrin levels, blood lead levels and neurocognitive deficits in Andean children with chronic lead exposure.
    Counter SA; Buchanan LH; Ortega F
    Clin Biochem; 2008 Jan; 41(1-2):41-7. PubMed ID: 18035344
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic value of zinc protoporphyrin in a screening strategy for alpha-thalassemia.
    Sardón Estévez N; Herruer MH; Jansen R; Bergkamp FJ; Gorgels JP
    Eur J Haematol; 2009 May; 82(5):393-7. PubMed ID: 19187279
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Zinc protoporphyrin (ZPP) in diagnosis of anemia].
    Paszkowska M; Jezyńska A; Król M; Rokicka-Piotrowicz M; Kuratowska Z
    Pol Arch Med Wewn; 1997 Dec; 98(12):520-6. PubMed ID: 9640080
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incidence and risk factors for bleeding in 1104 patients with essential thrombocythemia or prefibrotic myelofibrosis diagnosed according to the 2008 WHO criteria.
    Finazzi G; Carobbio A; Thiele J; Passamonti F; Rumi E; Ruggeri M; Rodeghiero F; Randi ML; Bertozzi I; Vannucchi AM; Antonioli E; Gisslinger H; Buxhofer-Ausch V; Gangat N; Rambaldi A; Tefferi A; Barbui T
    Leukemia; 2012 Apr; 26(4):716-9. PubMed ID: 21926959
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relevance of bone marrow features in the differential diagnosis between essential thrombocythemia and early stage idiopathic myelofibrosis.
    Thiele J; Kvasnicka HM; Zankovich R; Diehl V
    Haematologica; 2000 Nov; 85(11):1126-34. PubMed ID: 11064463
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Diagnosis and treatment of BCR/ABL-negative myeloproliferative diseases--principles and rationale of CZEMP recommendations].
    Schwarz J; Penka M; Campr V; Pospísilová D; Kren L; Nováková L; Bodzásová C; Brychtová Y; Cerná O; Dulícek P; Joniásová A; Kissová J; Korístek Z; Schützová M; Vonke I; Walterová L
    Vnitr Lek; 2011 Feb; 57(2):189-213. PubMed ID: 21416861
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.